Yahoo
TSXV - Delayed Quote CAD

NexgenRx Inc. (NXG.V)

0.6000 -0.0400 (-6.25%)
At close: October 23 at 1:59:49 PM EDT
Chart Range Bar
Loading chart for NXG.V
  • Previous Close 0.6400
  • Open 0.6400
  • Bid 0.6000 x --
  • Ask 0.6700 x --
  • Day's Range 0.6000 - 0.6400
  • 52 Week Range 0.2900 - 0.7500
  • Volume 75,775
  • Avg. Volume 16,237
  • Market Cap (intraday) 42.67M
  • Beta (5Y Monthly) 0.46
  • PE Ratio (TTM) 20.00
  • EPS (TTM) 0.0300
  • Earnings Date (est.) Aug 20, 2026
  • Forward Dividend & Yield 0.02 (3.33%)
  • Ex-Dividend Date Aug 28, 2026
  • 1y Target Est --

NexgenRx Inc. administers, adjudicates, and pays drug, dental, and other extended health-care claims for the beneficiaries of health benefit plans underwritten by its customers in Canada. The company offers NexSys claims management; NexAdmin plan administration; and NexPSPAssist patient support programs. It also provides proprietary computer software, and ancillary services. NexgenRx Inc. was incorporated in 2003 and is headquartered in Toronto, Canada.

www.nexgenrx.com

--

Full Time Employees

December 31

Fiscal Year Ends

Healthcare

Sector

Performance Overview

Trailing total returns as of 10/23/2026, which may include dividends or other distributions. Benchmark is S&P/TSX Composite index (^GSPTSE) .

YTD Return

NXG.V
53.20%
S&P/TSX Composite index (^GSPTSE)
12.31%

1-Year Return

NXG.V
63.60%
S&P/TSX Composite index (^GSPTSE)
18.56%

3-Year Return

NXG.V
161.85%
S&P/TSX Composite index (^GSPTSE)
87.90%

5-Year Return

NXG.V
78.18%
S&P/TSX Composite index (^GSPTSE)
68.68%

Statistics

View More

Valuation Measures

Annual
As of 10/23/2026
  • Market Cap

    42.67M

  • Enterprise Value

    41.03M

  • Trailing P/E

    19.35

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    2.39

  • Price/Book (mrq)

    5.51

  • Enterprise Value/Revenue

    2.12

  • Enterprise Value/EBITDA

    9.46

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    13.60%

  • Return on Assets (ttm)

    5.54%

  • Return on Equity (ttm)

    30.10%

  • Revenue (ttm)

    19.34M

  • Net Income Avi to Common (ttm)

    2.37M

  • Diluted EPS (ttm)

    0.0300

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    3.57M

  • Total Debt/Equity (mrq)

    2.97%

  • Levered Free Cash Flow (ttm)

    1.81M

Compare

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: